Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes. In lung cancer patients, immune-checkpoint inhibitors commonly cause thyroid problems, mostly mild hypothyroidism, affecting about 16% in one study and raising risk…
KRAS mutations, found in most pancreatic adenocarcinomas, help build an immunosuppressive tumor microenvironment that blocks immune attack and resists therapy [2][5][6].
Optimization of CAR T-cell therapy for immune-mediated diseases focuses on improving safety, precision, and durability through genetic engineering, metabolic reprogramming, and…
Across studies, intrathecal chemotherapy for lung cancer leptomeningeal metastasis produces objective response rates of roughly 34.5% to 86.4%, with higher rates in some…
Intrathecal therapy can shrink tumors and ease neurological symptoms in some patients with leptomeningeal metastasis, but benefits vary widely and it is not a cure.
Leptomeningeal metastasis from pancreatic cancer is rare and usually has a very short median survival of 1 to 2 months, but rare individual cases have lived longer with intensive…
Intrathecal chemotherapy through an Ommaya reservoir is a standard way to treat leptomeningeal metastasis, and comparative evidence suggests it may improve disease control and…
For EGFR-mutant lung cancer that has spread to the lining of the brain (leptomeningeal metastasis), studies point to osimertinib, sometimes combined with bevacizumab, and…
Intrathecal chemotherapy can shrink or stabilize leptomeningeal metastasis and may extend survival in some patients, but benefit varies by cancer type and the evidence is not…
Yes. Capecitabine is used in HER2-positive breast cancer, most often combined with anti-HER2 drugs, and it has shown benefit in metastatic disease, including brain metastases…
Retifanlimab is approved as a treatment for metastatic or recurrent locally advanced Merkel cell carcinoma, but it is not the standard first-line treatment for non-metastatic…
Some inherited gene mutations can raise the risk of both paraganglioma and thyroid cancer, but the sources do not show that paraganglioma directly causes thyroid cancer lymph…
For people with an SDHD mutation who develop paraganglioma, the risk of metastasis appears to be low, around 4% in one meta-analysis, much lower than for SDHB mutations [6].
CLDN18.2 is found in roughly 30% to 34% of gastric adenocarcinoma patients when using the stricter clinical cutoff, though rates vary by threshold and population [4][6].
Yes. Adding immune checkpoint inhibitors to chemotherapy improves pathological response rates in gastric adenocarcinoma, though the survival benefit is less consistent.
Yes. Fluorescence-guided imaging is already used in veterinary surgical oncology to help find and remove tumors, though it is not perfect and can miss or falsely flag tissue…
The CXCL16/CXCR6 axis acts as a "double-edged sword" in cancer, where it can either promote tumor growth and drug resistance or be targeted to inhibit tumor progression.
A single case report links pazopanib and axitinib to probable cholecystitis in a kidney cancer patient, but this is rare and based on limited evidence [1].
Molecular markers may improve risk assessment for oral potentially malignant disorders (OPMD) because traditional grading based on tissue appearance can be unreliable due to the…
Molecular markers show promise for improving risk assessment in oral potentially malignant disorders, but they are not yet proven better than standard histopathology and need…
A UK trial for relapsed Wilms tumor reported a 63% four-year event-free survival rate and a 68% overall survival rate.
Surgery is a standard treatment for epithelial-type Wilms tumor in both children and adults.
While Wilms tumor is primarily a childhood cancer, it can occur in adult women, though these cases are extremely rare.
While rare, Wilms tumor can recur many years after the initial diagnosis, with one documented case occurring 32 years after the first diagnosis.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.